Multi-tenant cloud SaaS eQMS plus AI compliance-intelligence layer, purpose-built for small-to-mid life-sciences companies (11–500 employees) seeking rapid (30–60 day) deployment with vendor-led validation in lieu of traditional IQ/OQ/PQ packages. Repositioned in October 2025 as a "Life Sciences GRC platform."
Qualio (vendor: Qualio Inc.) was founded in 2012 by Robert Fenton in Dublin and is now headquartered in San Francisco with engineering in Dublin and Wrocław. The vendor describes itself as the eQMS for "growing life-science companies with 11+ employees" and serves "over 500 companies in 80 countries" per Crunchbase. The product unifies document control, training, quality events (CAPA, NCR, deviations, complaints bundled into one "Events" object), supplier management, audits, change control, risk, and design controls in a single tenant. The product includes a native in-app web document editor, with no Word check-in/check-out step, and a validation model with a light customer-side footprint.
In October 2025, Qualio added Compliance Intelligence, an AI module that scans the tenant and connected systems for evidence-to-requirement mapping and gap detection against the FDA QMSR, ISO 13485, ISO 9001, ISO 27001, and MDSAP frameworks. The repositioning as a "Life Sciences GRC platform" coincided with this launch.
Customer base and review demographics skew heavily toward medical device — 36% of GetApp reviewers self-identify as medical device, the largest single segment. Pharma deployments use the same horizontal product line. Qualio raised $50M Series B in May 2021, led by Tiger Global with Menlo Ventures, for ~$63.7M–$66.2M total funding. Headcount per PitchBook stands at 114 in 2026, down from a 2021–2022 peak that anecdotally exceeded 200; Growjo records a -12% YoY employee change. Vendor self-classifies as GAMP 5 Category 4 (configured product).
Qualio is ISO 27001, ISO 9001, and ISO 27701 certified at the vendor level. The product is deployed as multi-tenant SaaS only; no native iOS or Android app is available — browser-only access.
Core Capabilities
FDA & GxP Compliance
International Standards
Security Certifications
Data Integrity & Validation
Multi-tenant SaaS cloud. Vendor does not advertise single-tenant or sovereign deployment options. Cloud provider not directly disclosed on vendor pages — a third-party Qualio integration developer states Qualio is hosted on AWS, consistent with the company's San Francisco engineering posture, but this is not a vendor-controlled attestation. EU data-residency option is not explicitly published. Access is browser-only; no native iOS or Android app is available.
SSO via SAML/OIDC with Azure / Microsoft 365, Google Workspace, and Okta connectors. SCIM-based automated user provisioning not publicly confirmed. Dual API surface: a legacy GraphQL API and a newer RESTful Developer API with token-scoped permissions across Documents, Events, Training, Users, Suppliers, Resource Library, and more. Pre-built connectors named in docs: Jira, Asana, TestRail, Xray, Zephyr Scale, Salesforce, Slack, OneDrive, Microsoft 365 / Azure AD, Google Workspace, Okta, ComplianceWire, Zapier. No XML / HL7 / IDMP / SPL data standards (Qualio is not positioned as a regulatory-submissions tool); data exchange is JSON-over-REST. No published tenancy-size ceiling, throughput benchmarks, or SLA percentages.
No public dollar pricing is published on the vendor page; all amounts require a sales call. Subscription is annual, across three published tiers — Foundation, Growth, Scale — plus a multi-instance add-on on Growth and Scale. Pricing combines a base platform fee, per-user seat charges, optional setup/onboarding fees, and optional content packs. OpenRegulatory characterises Qualio's pricing as "very intransparent."
Reported starting prices (none vendor-verified): softwareconnect.com cites a ~$12,000 base platform fee plus ~$3,000 per user. openregulatory.com cites at least €25K/year with 1–3 full seats and a setup fee of €8K–€20K. For a sub-50-employee biotech, Year-1 all-in subscription plus setup is estimated at $25K–$45K, escalating with seat count. Mid-cap (100–500 employee) deployments are reported at $50K–$120K+. A demo is available; there is no public self-serve free trial. The subscription carries a one-year minimum, and multi-year discounts are not published. At least one Capterra reviewer reports significant annual price escalation friction.
Vendor-published timeline is 30–60 days average implementation, with customer testimonials reporting ISO 13485 certification achieved in as little as 7 months. Practitioner reviews broadly corroborate the 30–60 day timeline for a Foundation-tier rollout in a sub-100-employee biotech, with the caveat that document migration from Word/Excel is the dominant time sink and consistently underestimated. Reformatting legacy SOPs into Qualio's web-native editor is the implementation friction point most frequently described.
Qualio's pricing page lists onboarding/setup as part of subscription tiers, but practitioner reports cite one-time setup fees of roughly €8,000–€20,000 (~$8K–$22K) in addition to subscription. Validation support, premium implementation, and "Content Pathways" (pre-built document template packs) appear to be priced as add-ons. CSV/Excel mass-import into the Resource Library is documented. Document migration from Word/Excel requires reformatting. API ingestion is supported via the Developer API. No named legacy-eQMS migrator tool published. Common pitfalls: underestimating document-reformatting effort, discovering that "Basic" read-only users still consume license seats, supplier and audit modules being less mature than document control, and reporting/export limitations.
Anonymous feedback from pharmaceutical professionals using this solution
4.4 out of 5
Based on 777 verified reviews
What Users Like
Users report praise for ease of use and short onboarding curve — repeated testimonials describe Qualio as "the most user-friendly system that I've ever used in my whole career" and "extremely straight forward to use." Document traceability and review-cycle automation are consistently called out, as is the @-mention linking that connects documents, events, suppliers, and users into a story of related records. Customer support is widely praised as responsive and knowledgeable during onboarding, migration, and issue resolution. Several reviewers credit validation documentation as easy to understand and execute, and the speed of audit preparation and ISO certification — with one customer citing ISO 13485 certification achieved in seven months — is a recurring strength theme.
What Users Dislike
Common complaints cluster around four areas. First, the native web document editor is described as "difficult to use, especially to preserve formatting for more complex documents" and "challenging to create documents with," with reviewers noting the absence of a folder/tree view leaves "a total lack of document structure or inventory for ease of navigation." Second, reporting and data export are repeatedly flagged ("inability to run reports, or export data for tracking/reporting outside of Qualio"). Third, certain modules are less mature than core document control — the supplier event capability is described as "brand new and not quite the finished product yet," and the unified Events object trades configurability for simplicity. Fourth, commercial friction surfaces consistently — read-only Basic users reportedly still consume paid license seats, and annual price escalations have driven at least one verified reviewer to actively evaluate alternatives. Absence of a native mobile app is also called out.
Help the community
Share your experience with Qualio anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section